Stockscreener 앱 받기
2.565
3.57%
-0.095
시장 영업 전:
2.66
0.095
+3.70%
전일 마감가:
$2.66
열려 있는:
$2.67
하루 거래량:
237.11K
Relative Volume:
0.78
시가총액:
$99.12M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-1.71
EPS:
-1.5
순현금흐름:
$-46.21M
1주 성능:
-5.35%
1개월 성능:
-12.16%
6개월 성능:
-54.76%
1년 성능:
-57.67%
1일 변동 폭
$2.56
$2.68
1주일 범위
$2.50
$2.75
52주 변동 폭
$2.37
$7.04
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.565 | 143.51M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Can Orchestra BioMed Holdings Inc. hit a new high this monthJuly 2025 Breakouts & Reliable Volume Spike Alerts - Newser
Is Orchestra BioMed Holdings Inc. stock bottoming outMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - Newser
Real time pattern detection on Orchestra BioMed Holdings Inc. stockEarnings Summary Report & Weekly Market Pulse Updates - Newser
Is Orchestra BioMed Holdings Inc. a candidate for recovery playWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Will Orchestra BioMed Holdings Inc. continue its uptrend2025 Momentum Check & Stock Portfolio Risk Management - Newser
What data driven models say about Orchestra BioMed Holdings Inc.’s future2025 Top Decliners & Reliable Entry Point Alerts - Newser
How hedge fund analytics apply to Orchestra BioMed Holdings Inc. stock2025 Earnings Surprises & Technical Buy Zone Confirmations - Newser
Best data tools to analyze Orchestra BioMed Holdings Inc. stockPrice Action & Daily Oversold Stock Bounce Ideas - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - Newser
Orchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart Disease - MyChesCo
Is a relief rally coming for Orchestra BioMed Holdings Inc. holdersEntry Point & Safe Capital Growth Trade Ideas - Newser
What the charts say about Orchestra BioMed Holdings Inc. today2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
Reversal indicators forming on Orchestra BioMed Holdings Inc. stockWeekly Stock Recap & Accurate Buy Signal Alerts - Newser
Real time scanner hits for Orchestra BioMed Holdings Inc. explainedTrade Risk Summary & Community Shared Stock Ideas - Newser
Signal strength of Orchestra BioMed Holdings Inc. stock in tech scannersShare Buyback & Fast Gain Stock Tips - Newser
Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN
Intrinsic Value of Orchestra BioMed Holdings Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - Newser
Can momentum traders help lift Orchestra BioMed Holdings Inc.2025 Top Gainers & Verified Entry Point Signals - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.Earnings Trend Report & Expert Approved Momentum Ideas - Newser
Will a bounce in Orchestra BioMed Holdings Inc. offer an exitQuarterly Trade Summary & Fast Moving Stock Watchlists - Newser
Understanding Orchestra BioMed Holdings Inc.’s price movementJuly 2025 Gainers & Weekly High Return Forecasts - Newser
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionJuly 2025 Reactions & Consistent Profit Trade Alerts - Newser
Will Orchestra BioMed Holdings Inc. see short term momentumEarnings Summary Report & High Yield Equity Trading Tips - Newser
Does Orchestra BioMed Holdings Inc. fit your quant trading modelJobs Report & AI Forecast Swing Trade Picks - Newser
How to integrate Orchestra BioMed Holdings Inc. into portfolio analysis toolsIPO Watch & Reliable Breakout Forecasts - Newser
Why Orchestra BioMed Holdings Inc. is moving today2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser
How cyclical is Orchestra BioMed Holdings Inc.’s revenue streamBreakout Watch & Growth Focused Entry Reports - mustnews.co.kr
Chardan Capital Reiterates Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Should you wait for a breakout in Orchestra BioMed Holdings Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
FDA Greenlights Broader Patient Access for AVIM Therapy Trial in Pacemaker Patients - MSN
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction - The Manila Times
Orchestra BioMed Announces Publication of AVIM Therapy - GlobeNewswire
Novel Heart Therapy Shows Dual Benefits: Reduces Blood Pressure While Improving Cardiac Function - Stock Titan
Detecting support and resistance levels for Orchestra BioMed Holdings Inc.Weekly Trend Report & Accurate Intraday Trading Signals - Newser
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.88%
자본화:
|
볼륨(24시간):